MedPath

Liothyronine Sodium

LIOTHYRONINE SODIUM TABLETS. These highlights do not include all the information needed to use LIOTHYRONINE SODIUM TABLETS safely and effectively. See full prescribing information for LIOTHYRONINE SODIUM TABLETS. LIOTHYRONINE SODIUM tablets, for oral use Initial U.S. Approval: 1956

Approved
Approval ID

ababc2ad-0458-663e-e053-2a95a90a5a86

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 3, 2023

Manufacturers
FDA

Golden State Medical Supply, Inc.

DUNS: 603184490

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Liothyronine Sodium

PRODUCT DETAILS

NDC Product Code51407-386
Application NumberANDA090097
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 3, 2023
Generic NameLiothyronine Sodium

INGREDIENTS (6)

CALCIUM SULFATE, UNSPECIFIED FORMInactive
Code: WAT0DDB505
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LIOTHYRONINE SODIUMActive
Quantity: 50 ug in 1 1
Code: GCA9VV7D2N
Classification: ACTIM

Liothyronine Sodium

PRODUCT DETAILS

NDC Product Code51407-385
Application NumberANDA090097
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 3, 2023
Generic NameLiothyronine Sodium

INGREDIENTS (6)

CALCIUM SULFATE, UNSPECIFIED FORMInactive
Code: WAT0DDB505
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LIOTHYRONINE SODIUMActive
Quantity: 25 ug in 1 1
Code: GCA9VV7D2N
Classification: ACTIM

Liothyronine Sodium

PRODUCT DETAILS

NDC Product Code51407-384
Application NumberANDA090097
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 3, 2023
Generic NameLiothyronine Sodium

INGREDIENTS (6)

CALCIUM SULFATE, UNSPECIFIED FORMInactive
Code: WAT0DDB505
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LIOTHYRONINE SODIUMActive
Quantity: 5 ug in 1 1
Code: GCA9VV7D2N
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Liothyronine Sodium - FDA Drug Approval Details